Other related reports showed that GpS protected against NAFLD progression by upregulating the expression of PPARα and downregulating the inflammatory cytokines, oxidative stress indices, and de novo lipogenesis (Gou et al., 2016; He et al., 2015; Qin et al., 2012). Here, NBEAL2 is linked to metabolic dysfunction-associated steatotic liver disease.